Real-World Outcomes Registry for NeuroOne Epilepsy Treatment System
Part of Brain & nervous system clinical trials.
This registry collects information from patients with drug-resistant epilepsy who receive a specialized brain implant and radiofrequency ablation procedure using the NeuroOne OneRF system. The goal is to understand how well this treatment works in real-world patients and track long-term outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with drug-resistant epilepsy (epilepsy that doesn't respond well to medications)
- You have received or plan to receive the EVO sEEG-RF brain implant
- You have undergone or plan to have radiofrequency ablation (a procedure that uses heat to treat epilepsy) with the OneRF system
- You or your legal guardian can understand the study and provide informed consent in writing
- If you are under 18, you may also need to sign a separate form agreeing to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new implanted device that stimulates the vagus nerve (a major nerve in your neck) to help reduce seizures in people whose epilepsy doesn't respond well to medications. The device is surgically placed under the skin and may help lower how often you have seizures.
This study tests a personalized, non-invasive brain stimulation method called tDCS for people with drug-resistant epilepsy that starts in one part of the brain. It aims to reduce seizures in those who cannot have surgery or have not been helped by surgery.
This study looks at how different brain scans (like MRI, PET, and EEG) can help find the exact spot where seizures start in people whose epilepsy hasn't been controlled by medicines. It aims to better understand drug-resistant epilepsy so doctors can plan more accurate treatments.
This study is looking at how well a procedure called SEEG thermocoagulation (a way to stop seizures by heating a small area of brain tissue) works for people with epilepsy that doesn't improve with medication. By joining, you will help doctors understand why this treatment works for some people and not others.
This trial tests a new device to help diagnose epilepsy in people whose previous EEG brain monitoring did not give clear answers. If you have drug-resistant epilepsy with at least one seizure a month on average, this study may help find better treatment options.
This study looks at children with difficult-to-control epilepsy who are already scheduled for a special brain monitoring test with wires inside the skull. It observes how their seizures and brain activity change during the stay.
Hear when a new Drug Resistant Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.